COMPANY PROFILE / #1105
DeepSight Technology
Santa Clara, CAVenture Capital-Backed
OVERVIEW
Operator of medical imaging technology intended to transform ultrasound into a precision platform for real-time guidance during interventional procedures. The company offers proprietary sensing technology, customizable systems, and integration with industry partners, enabling clinicians to gain deeper insights, improve accuracy, and achieve better patient outcomes.
已融资116.50
最新估值217.50
员工数56
成立年份2019
公司概况
- Companies
- DeepSight Technology
- Description
- Operator of medical imaging technology intended to transform ultrasound into a precision platform for real-time guidance during interventional procedures. The company offers proprietary sensing technology, customizable systems, and integration with industry partners, enabling clinicians to gain deeper insights, improve accuracy, and achieve better patient outcomes.
- Website
- deepsight.com
- HQ Location
- Santa Clara, CA
- Year Founded
- 2019
- Keywords
- diagnostic medical, diagnostic technology, healthcare investment, interventional cardiology, interventional device, interventional devices, interventional neuroradiology, medical imaging technology, medical ultrasound, minimally invasive medical devices, minimally invasive technologies, ultrasound tools
- Competitors
- SigTuple, RADLogics, Zebra Medical Vision, IBEX Innovations, Pie Medical Imaging, goBalto, MedyMatch Technology, Meddiff Technologies, Emids Technologies, Aidence, Signant Health, NeuroLogica, Avreo, Advantis Medical Imaging, Midmark, Nuance Communications, Vista.ai, Circle Cardiovascular Imaging, Orchard Software, Imbio, Arterys, Intelerad Medical Systems, Quantib, Aidoc, Uptake Medical, Pro Medicus, ArisGlobal, Carestream Health, CitiusTech, VIDA (Discovery Tools), NinePoint Medical, Agfa HealthCare, Aycan Medical Systems, Benvenue Medical, Genetesis, Analogic, Invicro, Novarad, Creavo Medical Technologies, Delft Diagnostic Imaging, Tristan Technologies
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 116.50
- First Financing Date
- —
- First Financing Size
- 4.00
- First Financing Valuation
- 13.00
- Last Financing Date
- 19-Aug-2025
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- 60.00
- Last Financing Valuation
- —
- Last Financing Status
- Completed
- Last Known Valuation
- 217.50
- Last Known Valuation Date
- 15-Sep-2024
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 362.39
- Valuation Estimate Growth Rate
- 66.62%
- Active Investors
- Alter (Lisbon), Deerfield Management, Duggan Investments (Florida), EDBI, RONA Holdings, Time BioVentures, Wing Venture Capital
- # Active Investors
- 7
- Acquirers
- —
团队与联系人
- Employees
- 56
- Employee Growth %
- 30.23%
- Employee History
- 2025: 56, 2024: 43, 2023: 32, 2022: 20, 2021: 6
- Primary Contact
- Nader Sadrzadeh
- Primary Contact Title
- Co-Founder, Chief Executive Officer & Board Member
- Primary Contact Email
- nsadrzadeh@deepsight.com
- Primary Contact Phone
- —
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- 0.00%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 13
- Size Multiple
- 2.31x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 72
- Majestic Referring Domains
- 60
- SimilarWeb Unique Visitors
- 362
- SimilarWeb Unique Visitors Change
- 24
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- —
- Success Probability Over Time – 3 Year
- —
- Success Probability Over Time – 5 Year
- —
记录来源：public.companies · 原始序号 #1105 · 所有字段均按数据库原值展示。